Ethested Posted May 22, 2022 Share Posted May 22, 2022 Hey all, Just wanted to share a new small molecule being developed by TechoDerma medicines. They are trialing their drug TDM-105795 / TMI-105795 to treat androgenic alopecia and are currently in phase 1b after having successfully completed phase 1a, in the US. It's a topical which works via local Thyroid Receptor beta 1 agonism. The original research stems from Pfizer, who saw hair growth in stump-tailed macaques with such a drug. The technoderma team is also mostly ex-Pfizer. In 2016 such a compound has also been proven to work on human hair follicles ex-vivo, by Ralf Paus. I requested a comment from him on why his research didn't continue, and he said that it DEFINITELY should be pursued but funding and legal issues with the substance IP owner prohibited him. TechnoDerma Medicines Pipeline: http://tkskin.com/en/index.php?a=lists&catid=24 Phase 1 dosing announcement: http://tkskin.com/en/index.php?a=shows&catid=16&id=15 4 Link to comment Share on other sites More sharing options...
Regular Member davidn Posted July 9, 2022 Regular Member Share Posted July 9, 2022 Believe it or not I talked to Ralf Paus about the drug a few weeks ago. He was not too convinced. Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now